Sanofi's pill becomes first US-approved drug for rare neurological disorder
Reuters

Sanofi's pill becomes first US-approved drug for rare neurological disorder

Nov 18 (Reuters) - The US FDA on Wednesday approved Sanofi's oral drug venglustat, the first treatment approved for a type of rare genetic condition affecting the brain and nervous system. The drug, branded as Infilbray, is approved to treat type 3 Gaucher disease, the neurological variant of the di
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.